Helius Medical Technologies, Inc.

Helius Medical Technologies, Inc.

$0.91
0.46 (101.33%)
NASDAQ Capital Market
USD, US
Medical - Devices

HSDT Price Chart

Basic
Market Cap$1.86M
Price$0.91
52 Week Range0.373-9.5
Beta1.61
Margins
Gross Profit Margin-6.18%
Operating Profit Margin-2590.04%
Net Profit Margin-1764.74%
Valuation (TTM)
P/E Ratio-0.38
Price to Sales Ratio6.76
Price to Book Ratio0.90
PEG Ratio-0.01

Industry

Medical - Devices

Sector

Healthcare

Full-Time Employees

22

IPO Date

2014-06-27T00:00:00.000Z

Description

Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator (PoNS), is a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company is headquartered in Newtown, Pennsylvania.

Phone

215 944 6100

Address

642 Newtown Yardley Road, Newtown, PA, 18940, US

CIK

0001610853